| 发明名称 |
Single dose use of CD20-specific binding molecules |
| 摘要 |
The present invention provides materials and methods for treatment of diseases involving aberrant B-cell activity using a single dose of CD20-specific binding molecule. |
| 申请公布号 |
US2008213273(A1) |
申请公布日期 |
2008.09.04 |
| 申请号 |
US20060493241 |
申请日期 |
2006.07.25 |
| 申请人 |
TRUBION PHARMACEUTICALS INC. |
发明人 |
BURGE DANIEL J. |
| 分类号 |
A61K39/395;A61P19/02 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
